Qiming Venture Partners
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Growth, Series A, Series B, Series C, Series D
Geographical Focus
United States, United Kingdom, Canada, Germany, Hong Kong, Japan, Australia, Singapore, China, India, Brazil, France, United Arab Emirates, Mexico, South Korea, Saudi Arabia, Turkey, South Africa, Russia, Israel
Industries Focus
- Technology
- Healthcare
- Energy
- Real Estate
- Telecommunications
- Media
- Automotive
- Retail
- Education
- Agriculture
- Consumer
- FinTech
- E-commerce
- Logistics
- Artificial Intelligence
- Information Technology
- Biotechnology
- Cleantech
- Clean Technology
- IT
- Media and Internet
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2006
Qiming Venture Partners is a prominent venture capital firm based in China, specializing in early and growth-stage investments in technology and healthcare sectors. The firm has a strong presence in China, with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. As of August 2024, Qiming manages assets totaling US$9.5 billion, reflecting its significant influence in the venture capital landscape.
The firm's investment strategy focuses on identifying and supporting innovative companies across various industries, including technology, healthcare, and consumer sectors. Qiming has a diverse portfolio, with over 580 companies, many of which have achieved successful exits through IPOs and mergers and acquisitions. Notable portfolio companies include Xiaomi, Meituan, Bilibili, and Zhihu.
Qiming's approach combines deep technical expertise with strong operational experience, providing entrepreneurs with not only financial support but also strategic guidance and industry resources. This hands-on approach has contributed to the firm's reputation as a trusted partner for companies aiming to scale and succeed in competitive markets.
Requirements
- Innovative technology or healthcare companies with high growth potential
- Strong management teams
- Scalable business models
- Strong growth potential
- Innovative business models
- Experienced management teams
- Scalable operations
- Competitive market positioning
- Scalable growth potential
- Clear path to profitability
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Xiaomi
- Meituan
- Bilibili
- Zhihu
- Roborock
- UBTech
- WeRide
- HyperStrong
- Insta360
- Unisound
- Gan & Lee Pharmaceuticals
- Tigermed
- Zai Lab
- CanSino Biologics
- Schrödinger
- APT Medical
- Sanyou Medical
- AmoyDx
- Berry Genomics
- SinocellTech
- Cansinotech
- Mafengwo
- Tellgen
- Miaoshou Doctor
- Transwarp
- Tujia
- Longwood Biopharmaceuticals
- Yuanxin Technology
- Insilico Medicine
Mentioned In
-
$49.95
-
$39.95
-
$24.95
-
$19.95
-
$9.95
-
$19.95
-
$24.95
-
$19.95
Claim this Investor
Are you an official representative of Qiming Venture Partners?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim